Chylomicron: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Chylomicron}} | ||
{{CMG}}; {{AE}} {{AN}}; {{RT}} | {{CMG}}; {{AE}} {{AN}}; {{RT}} | ||
Line 28: | Line 28: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Lipoproteins]] | [[Category:Lipoproteins]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 17:09, 12 September 2013
Chylomicron Microchapters |
Clinical Correlation |
---|
Treatment |
Case Studies |
Chylomicron On the Web |
American Roentgen Ray Society Images of Chylomicron |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High chylomicron
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low chylomicron
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies